Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lea Fritz"'
Autor:
Berislav Bošnjak, Elisa Henze, Yvonne Lueder, Kim Thi Hoang Do, Alaleh Rezalotfi, Berislav Čuvalo, Christiane Ritter, Anja Schimrock, Stefanie Willenzon, Hristo Georgiev, Lea Fritz, Melanie Galla, Karen Wagner, Martin Messerle, Reinhold Förster
Publikováno v:
Cell Reports, Vol 42, Iss 6, Pp 112597- (2023)
Summary: Murine cytomegalovirus (MCMV) infection of macrophages relies on MCMV-encoded chemokine 2 (MCK2), while infection of fibroblasts occurs independently of MCK2. Recently, MCMV infection of both cell types was found to be dependent on cell-expr
Externí odkaz:
https://doaj.org/article/4f0929654e204d4eb067896845d94756
Autor:
Madeleine C. Killer, Philipp Nold, Katharina Henkenius, Lea Fritz, Tabea Riedlinger, Christina Barckhausen, Miriam Frech, Holger Hackstein, Andreas Neubauer, Cornelia Brendel
Publikováno v:
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-8 (2017)
Abstract Background Mesenchymal stem cells (MSCs) have entered the clinic as an Advanced Therapy Medicinal Product and are currently evaluated in a wide range of studies for tissue regeneration or in autoimmune disorders. Various efforts have been ma
Externí odkaz:
https://doaj.org/article/a4507faa12cd44dd8284316bb1d82769
Autor:
Berislav Bošnjak, Elisa Henze, Yvonne Lueder, Kim Thi Hoang Do, Alaleh Rezalofti, Christiane Ritter, Anja Schimrock, Stefanie Willenzon, Hristo Georgiev, Lea Fritz, Melanie Galla, Karen Wagner, Martin Messerle, Reinhold Förster
SummaryMurine cytomegalovirus (MCMV) infection of macrophages relies on MCMV-encoded chemokine 2 (MCK2) through one or more unknown cellular receptors while infection of fibroblast occurs independent of MCK2 and is mediated by cell-expressed neuropil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa41b98a8cf9319bdbae1a1e4d67ee03
https://doi.org/10.1101/2022.10.05.510922
https://doi.org/10.1101/2022.10.05.510922
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 1689, p 1689 (2022)
Adaptive T-cell immunotherapy holds great promise for the successful treatment of leukemia, as well as other types of cancers. More recently, it was also shown to be an effective treatment option for chronic virus infections in immunosuppressed patie